Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.19.3
Consolidated Balance Sheets - USD ($)
Jul. 31, 2019
Jul. 31, 2018
Current assets    
Cash and cash equivalents $ 25,147,780 $ 3,803,627
Prepaid expenses and other current assets 3,359,556 1,643,749
Investment securities 23,174,447
Total Current Assets 28,507,336 28,621,823
Property and equipment, net 1,031,129 1,265,662
Other long-term assets 353,547 358,987
Total Assets 29,892,012 30,246,472
Current liabilities    
Accounts payable and accrued liabilities 4,217,017 4,778,892
Accrued compensation related 676,223 1,070,744
Note payable 83,760
Total Current Liabilities 4,977,000 5,849,636
Other long-term liabilities 635,913 1,472,630
Total Liabilities 5,612,913 7,322,266
Commitments and Contingencies (Note 10)
Stockholders' Equity    
Common stock authorized - 16,000,000 common shares with a par value of $0.0001, common stock issued and outstanding - 10,633,043 and 5,351,290 common shares as of July 31, 2019 and July 31, 2018, respectively 1,063 535
Additional paid-in capital 177,656,149 145,749,189
Warrants issued and outstanding - 3,631,953 and 895,805 warrants as of July 31, 2019 and July 31, 2018, respectively 10,809,724 11,271,327
Accumulated other comprehensive income (loss) 169,037 (16,024)
Accumulated deficit (164,356,874) (134,080,821)
Total Stockholders' Equity 24,279,099 22,924,206
Total Liabilities and Stockholders' Equity $ 29,892,012 $ 30,246,472